Physician profile
Arash Rahi
NPI 1801951868
$23,108.26
in general payments reported to CMS, 2019-2025
27 companies · $9,581 in 2025
The $9,581 reported for 2025 was more than what 94% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $589 · 2021: $306 · 2022: $2,161 · 2023: $7,146 · 2024: $1,998 · 2025: $9,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $2,909 · Travel and Lodging: $2,155 · Entertainment: $19.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,641.00 |
| Food and Beverage | $2,908.82 |
| Travel and Lodging | $2,155.16 |
| Entertainment | $19.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $17,112.13 | 2019-2025 | Altis, Supris, Saffron |
| Medtronic, INC. | $3,549.44 | 2022-2025 | Interstim, Altaviva |
| Abbvie INC. | $388.17 | 2019-2025 | |
| Femselect INC. | $303.95 | 2024-2025 | Enplace |
| Therapeuticsmd, INC. | $285.79 | 2019-2021 | |
| Caldera Medical, INC | $255.42 | 2021-2023 | Desara |
| Astellas Pharma US INC | $239.01 | 2019-2023 | Veozah |
| Heron Therapeutics, INC. | $122.18 | 2025 | Zynrelef, Aponvie |
| Medtronic USA, INC. | $119.18 | 2019 | |
| Axonics, INC. | $110.19 | 2022-2023 | Axonics |
| Bluewind Medical | $75.97 | 2025 | Revi |
| Laborie Medical Technologies Corp. | $74.31 | 2024 | Nxt, Eclipse, Urgent Pc Neuromodulation System |
| Smith+Nephew, INC. | $56.90 | 2021 | |
| Allergan, INC. | $55.41 | 2019-2021 | |
| Conmed Corporation | $49.55 | 2023-2024 | Airseal, Conmed Handheld Instruments |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $47.28 | 2023 | Solyx Sis System |
| Pfizer INC. | $41.84 | 2021-2022 | |
| Provepharm INC. | $38.31 | 2024-2025 | Bludigo |
| Convatec INC. | $33.93 | 2025 | |
| Hologic Sales and Service, LLC | $33.50 | 2025 | Aptima |
| Ethicon US, LLC | $28.03 | 2025 | Surgicel Nu-Knit, Vistaseal |
| Duchesnay USA Incorporated | $21.69 | 2019 | |
| Mimedx Group, INC. | $15.79 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $14.04 | 2023 | Seglentis |
| Escala Medical INC. | $12.84 | 2025 | |
| Amniox Medical, INC. | $11.94 | 2020 | |
| Ambu INC. | $11.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Rahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.